BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• ChoiceSpine™ Announces Full Market Release of Next Generation Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System

  ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces today that it has launched its next-generation Harrier™ SA ALIF System.

  April 19, 2022

   · 

  3 min read
• THE HIGHLY NOVEL SCIENCE BEHIND THE NEXT GENERATION OF DRUGS COMBATTING ABUSE AND OVERDOSE

  The world is experiencing a crisis in prescription drug abuse and overdose, with two of the major crisis areas in the treatment of pain and anxiety.

  April 19, 2022

   · 

  2 min read
• Business

  Genomma Lab Announces First Quarter 2022 Financial Results Call and Webcast

  Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), today announced that it will report its First Quarter 2022 results on Wednesday, April 27, 2022 after the Mexican Market (BMV) close.

  April 19, 2022

   · 

  2 min read
• BioForest

  AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at Life Science Innovation Northwest

  AVM Biotechnology announced that Founder and Chief Science Officer, Dr. Theresa Deisher, will provide an invited company presentation as well as a poster presentation at Life Science Innovation Northwest taking place April 20-21, at the Washington State Convention Center in Seattle.

  April 19, 2022

   · 

  5 min read
• Policy

  Extended SpagoPix Patent Protection in Japan

  Spago Nanomedical AB has received notice from the Japanese Patent Office that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D.

  April 19, 2022

   · 

  1 min read
• Business

  Cincinnati Children’s and CTI Announce Name and Managing Director of Joint Venture

  Named Current Biologics, as a nod to both the cutting-edge technologies it will help develop and the Ohio River that connects Northern Kentucky and Cincinnati, the company will be led by Robert Preti, PhD.

  April 19, 2022

   · 

  5 min read
• Business

  Cerevance Announces Leadership Transition to Implement Next Phase of Growth in Advancing Novel Therapeutics for Brain Diseases

  Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system diseases, today announced the appointment of Craig Thompson to chief executive officer.

  April 19, 2022

   · 

  2 min read
• Companion Diagnostics Market Value to Reach US$ 9.30 Bn by 2030

  The global companion diagnostics market is expected to reach the value of US$ 9.30 Bn by the end of 2030 and it is estimated to expand at a CAGR of 9% from 2021 to 2030.

  April 19, 2022

   · 

  11 min read
• Deep Brain Stimulation Devices Market Size, Share, Report 2021-2030

  The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by 2030 and it is estimated to expand at a CAGR of 5.1% from 2021 to 2030.

  April 19, 2022

   · 

  10 min read
• Pharm Country

  Hoth Therapeutics Announces New Pipeline Asset, HT-TBI for Stroke and Traumatic Brain Injury

  Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the company is adding a new asset to its pipeline portfolio, HT-TBI, which is based on scientific research performed by Hoth.

  April 19, 2022

   · 

  6 min read